Procter & Gamble Health Ltd announced a strong financial performance for the January-March quarter, with net profit surging 31% to Rs 61 crore and net sales increasing 23% to Rs 304 crore year-on-year. The company credited its growth to effective brand-building efforts and enhanced supply chain and go-to-market strategies. Additionally, P&G Health revised its fiscal year, transitioning from a July-June cycle to an April-March calendar, resulting in a nine-month financial year for 2024-25.